| Literature DB >> 34296117 |
N Frezel1, E Platonova2, F F Voigt3,4, J M Mateos2, R Kastli3,4, U Ziegler2, T Karayannis3,4, F Helmchen3,4, H Wildner1, H U Zeilhofer1,5.
Abstract
Neuronal circuits of the spinal dorsal horn integrate sensory information from the periphery with inhibitory and facilitating input from higher central nervous system areas. Most previous work focused on projections descending from the hindbrain. Less is known about inputs descending from the cerebral cortex. Here, we identified cholecystokinin (CCK) positive layer 5 pyramidal neurons of the primary somatosensory cortex (CCK + S1-corticospinal tract [CST] neurons) as a major source of input to the spinal dorsal horn. We combined intersectional genetics and virus-mediated gene transfer to characterize CCK+ S1-CST neurons and to define their presynaptic input and postsynaptic target neurons. We found that S1-CST neurons constitute a heterogeneous population that can be subdivided into distinct molecular subgroups. Rabies-based retrograde tracing revealed monosynaptic input from layer 2/3 pyramidal neurons, from parvalbumin positive cortical interneurons, and from thalamic relay neurons in the ventral posterolateral nucleus. Wheat germ agglutinin-based anterograde tracing identified postsynaptic target neurons in dorsal horn laminae III and IV. About 60% of these neurons were inhibitory and about 60% of all spinal target neurons expressed the transcription factor c-Maf. The heterogeneous nature of both S1-CST neurons and their spinal targets suggest complex roles in the fine-tuning of sensory processing.Entities:
Keywords: AAV-based viral tracing; CCK; corticospinal tract; dorsal spinal cord; somatosensory cortex
Year: 2020 PMID: 34296117 PMCID: PMC8152836 DOI: 10.1093/texcom/tgaa052
Source DB: PubMed Journal: Cereb Cortex Commun ISSN: 2632-7376
Materials and reagents
| Materials | Resource | Identifier |
|---|---|---|
|
| ||
| C57BL/6J (wild type) | The Jackson Laboratory | IMSR_JAX:000664 |
| C57BL/6.FVB-Tg(Slc6a5-EGFP)13Uze (GlyT2::eGFP) | IPT (Zurich, Switzerland) | MGI:3835459, |
| Cck<tm1.1(cre)Zjh>/J (CCKCre) | Jackson Laboratory |
|
|
| ||
| rAAV-retro/2-shortCAG-dlox-EGFP | VVF (Zurich, Switzerland) | This publication (vHW22-retro) |
| rAAV-retro/2-shortCAG-tdTomato | VVF (Zurich, Switzerland) | v131-retro |
| rAAV-retro/2-hEF1a-DreO | VVF (Zurich, Switzerland) | v127-retro |
| ssAAV-DJ/2-hEF1a-DreO | VVF (Zurich, Switzerland) | v127-DJ |
| rAAV-9/2-hEF1α-Don/Con-EGFP | VVF (Zurich, Switzerland) | This publication (vHW18–1) |
| rAAV-retro/2-hCMV-Cre | VVF (Zurich, Switzerland) | v36-retro |
| rAAV1-CAG-flex.eGFP | Penn Vector Core (Philadelphia, USA) | V3675TI-Pool |
| rAAV-8/2-hSyn1-roxSTOP-dlox-TVA_2A.RabG | VVF (Zurich, Switzerland) | This publication (vHW7–1) |
| SAD.RabiesΔG.eGFP (EnvA) (EnvA.RV.dG.eGFP) | Salk Institute (La Jolla, CA, USA) |
|
| AAV1-CAG-flex-tdTom | Penn Vector Core (Philadelphia, USA) | AllenInstitute854 |
| rAAV2-EF1α-flex-WGA | IPT (Zurich, Switzerland) | This publication |
| ssAAV-1/2-hSyn1-dlox-mSyp1-EGFP | VVF | vHW41.1 |
|
| ||
| Goat anti-Pax2 (1:400) | R&D Systems (Minneapolis, MN, USA) | AB_10889828 |
| Guinea pig anti-Lmx1b (1:10 000) | Dr Carmen Birchmeier |
|
| Chicken anti-GFP (1:1000) | Life Technologies ( | AB_2534023 |
| Rabbit anti-GFP (1:1000) | Molecular Probes ( | AB_221570 |
| Rabbit anti-NeuN (1:1000) | Abcam ( | AB_10711153 |
| Guinea pig anti-NeuN (1:1000) | Synaptic System (Göttingen, D) | AB_2619988 |
| Goat anti-WGA (1:2000) | VECTOR laboratories (Burlingame, CA, USA) | AS-2024 |
| Rabbit anti-WGA (1:2000) | Sigma Aldrich ( | T4144 |
| Rabbit anti-c-Maf (1:1000) | Dr Carmen Birchmeier | #40 |
| Guinea pig anti-c-Maf (1:1000) | Dr Carmen Birchmeier | #2223, #1 Final bleed |
| Rabbit anti-PKCg (1:1000) | Santa Cruz (Dallas, Texas, USA) | AB_632234 |
| Rabbit anti-SST (1:1000) | Santa Cruz (Dallas, Texas, USA) | sc-13099 |
| Mouse anti-PV (1:1000) | Swant (Marly, Switzerland) | 235 |
| Guinea pig anti-PV (1:1000) | Immunostar (Hudson, WI) | 24428 |
| Rabbit anti-NPY (1:1000) | Peninsula Laboratories (San Carlos, CA, USA) | T-4069 |
| Rabbit anti-TVA | Dr Sauer |
|
| Goat anti-tdTomato (1:1000) | Sicgen (Cantanhede, Portugal) | AB8181-200 |
| Rabbit antihomer | Synaptic System (Göttingen, D) | AB_2120990 |
| Guinea pig antihomer | Synaptic System (Göttingen, D) | AB_10549720 |
|
| ||
| CCK | ACD | Mm-CCK-C1 |
| CRE | ACD | CRE-C3 |
| GFP | ACD | Mm-GFP-C3 |
| RORα | ACD | Mm-Rora-C2 |
| Crhr1 | ACD | Mm-Crhr1-C2 |
| Etv1 (Er81) | ACD | Mm-Etv1-O1-C1 |
| Bcl11b (Ctip2) | ACD | Mm-Bcl11b-C1 |
| Htr2c (5-HTR2c) | ACD | Mm-Htr2c-C1 |
| GABARγ1 | ACD | Mm-Gabrg1-C1 |
| Plxnd1 | ACD | Mm-Plxnd1 |
| Nr4a2 (Nurr1) | ACD | Mm-Nr4a2-C1 |
| Triplex positive control probe | ACD | 3-plex Positive Control Probe- Mm |
| Triplex negative control probe | ACD | 3-plex Negative Control Probe- Mm |
Notes: IPT: Institute of Pharmacology and Toxicology, University of Zurich; VVF: Viral Vector Facility (University of Zurich; www.vvf.uzh.ch)
Figure 1
Labeling S1-CST neurons in CCKCre mice. (A) Injection of rAAVs encoding for Cre-dependent eGFP and Cre-independent tdTomato fluorescent proteins into the lumbar spinal cord of CCKCre mice (n = 4 mice). (B) Brain areas labeled with eGFP positive neurons after intraspinal injection of rAAV2retro.flex.eGFP in CCKCre mice. 7N: facial nuclei, ACC: anterior cingulate cortex, MnR: median raphe nucleus, PAG: Periaqueductal gray, S1hl: somatosensory cortex, hindlimb area. (C) Comparison of S1-CST neurons labeled by Cre-dependent eGFP and Cre-independent tdTomato (n = 4, 3166 neurons) fluorescent proteins. (D) Quantification of (C). (E) Injection of rAAVs encoding for Cre-dependent tdTomato into the S1 cortex of CCKCre mice. (F) Widespread labeling of cortical neurons with tdTomato (red) after cortical injection (E). Error bars represent ±SEM. Scale bars: B: 1 mm; C and F: 200 μm.
Figure 2
Three viral targeting strategies to label S1-CST neurons. (A) S1-CST neurons labeling using a rAAV2-retro-tdTomato injected in the lumbar spinal cord of wild-type mice. (B) S1-CST neurons labeling using the rAAV2-retro-Dre injected in the lumbar spinal cord of CCKCre mice, followed by cortical (S1) injection of AAV.Con/Don-eGFP. (C) S1-CST neurons labeling using the rAAV2-retro-Cre injected in the lumbar spinal cord of wild-type mice, followed by cortical (S1) injection of AAV.flex-eGFP. (D) Quantification of the number of neurons labeled per mouse in (A–C) (A: n = 4 mice, 1546 neurons; B: n = 3 mice, 1136 neurons and C: n = 3 mice, 418 neurons). (E) Diagrams showing the 3 injections strategies used in (A), (B), and (C), respectively. Error bars represent: ±SEM. Scale bars: 100 μm.
Figure 3
Multiplex ISH in GFP-labeled CCKCre neurons with cortical neurons markers in S1. (A–E) Triple ISH showing the colocalization of GFP with CCK and crhr1 (A), gabrg1 and er81 (B), htrc2 and ctip2 (C), nurr1 and RORα (D), Plxnd1 (E). (F) Quantification of (A–E) (n = 3 mice; 352, 221, 85, 243, and 278 GFP neurons, respectively). Error bars represent ±SEM. Scale bars: 50 μm.
Figure 4
Labeling of the corticospinal tract in CLARITY-cleared brain. The whole CNS of mice expressing eGFP only in lumbar spinal cord projecting CST neurons was dissected and subjected to passive clearing and light sheet imaging. (A) Schematic drawing of the mouse CNS. Injection sites of the viruses and optical planes shown in B–K are depicted. (B) eGFP labeling of S1-CST neurons in S1. The axons enter the corpus callosum and a small subset of collaterals bifurcates to the dorsal striatum (CPu). (C) Coronal view of the termination area in the CPu. (D) Sagittal view of collaterals branching of from the main CST towards the thalamus. (E) Horizontal view of the CST decussation at the entry of the spinal cord. (F,I) Horizontal and coronal views of the CST at the level of the cervical spinal cord. (G,J) Horizontal and coronal views of the CST at the level of the thoracic spinal cord. (H,K) Horizontal and coronal views of the CST at the level of the lumbar spinal cord. Inset in (K) shows CST terminals branching in the dorsal horn. White arrows: CST terminals branching in the spinal cord at the lumbar level only. Dashed arrows: dorsolateral tract (secondary part of the CST). CPu: Striatum; S1: primary somatosensory cortex (hindlimb area here); SC: spinal cord; a.: anterior, p.: posterior, d.: dorsal, v.: ventral. B, D–K: Volume renderings (Imaris); C: optical section. (n = 3 mice). Scale bars: 1 mm.
Figure 5
Retrograde monosynaptic tracing of S1-CST neurons with rabies. rAAV2retro.Dre was injected into the spinal cord of CCKCre mice, followed by a Cre-and-Dre-dependent helper virus (TVA, RabG) into S1. Two weeks later the pseudotyped rabies virus was injected into S1. (A) Overview of the labeled neurons in the brain: S1-CST neurons (starter cells) as well as layer 2/3 pyramidal neurons, thalamic sensory relay neurons, and layer 5 inhibitory interneurons. (B) Quantification of retrogradely labeled neurons (GFP+TVA−) represented in (C–I). (C,D) Retrogradely labeled thalamic sensory relay neurons in the VPL of the thalamus (n = 3 mice, 1481 GFP+ neurons). (E,F) Retrogradely labeled layer 2/3 pyramidal neurons (n = 3 mice, 1481 GFP+ neurons). (G–I) Retrogradely labeled layer 5 inhibitory interneurons, with costaining against PV (G, n = 3 mice, 513 neurons), NPY (H, n = 3 mice, 196 GFP+ neurons) or SST (I, n = 3 mice, 968 GFP+ neurons). Error bars represent ±SEM. Scale bars: A: 1 mm; C–I: 100 μm.
Figure 6
Labeling of the output of S1-CST neurons in the spinal cord. (A) Labeling of the CST in the dorsal funiculus of the spinal cord, contralateral to the brain injection site after injection of a rAAV carrying a Cre-dependent tdTomato into S1hl of CCKCre mice. CST terminals are preferentially located below the laminae II-III border (n = 3). (B) Quantification of the number of WGA positive neurons after injection of a rAAV.flex.WGA into S1hl of CCKCre mice. Quantified are WGA positive neurons that express Lmx1β (n = 4, 320 WGA+ neurons), Pax2 (n = 8, 391 WGA+ neurons), GlyT2 (n = 3, 275 WGA+ neurons), c-Maf (n = 6, 506 WGA+ neurons), or PKCγ (n = 4, 201 WGA+ neurons). (C,D) Representative images of colabeled WGA positive neurons in the spinal cord with the excitatory marker Lmx1β ((C) and inset) and the inhibitory marker Pax2 ((D) and inset). Neurons expressing eGFP under the GlyT2 promoter (using the GlyT2::eGFP mouse line (E)), and neurons expressing the transcription factor c-Maf (F) were also found positive for WGA. (G,H) Verification of monosynaptic labeling by WGA. CCKCre Mice were coinjected with rAAV.flex.WGA and rAAV.flex.Syp-eGFP (encoding a Cre-dependant synaptophysin-eGFP fusion protein) into S1hl. (G) Colabeling of WGA positive neurons in the spinal cord with the neuronal marker NeuN and eGFP labeled presynaptic terminals of S1-CST neurons. Depicted is a representative example of a WGA+ neuron in close proximity to a eGFP+ presynaptic terminal of a S1-CST neuron3. (H) Quantification of the number of WGA+ neurons receiving direct contacts from eGFP+ synaptic terminals (n = 4 mice; 25 neurons). CST: corticospinal tract. Error bars represent ±SEM, Scale bars: A and C–F: 100 μm; G: 10 μm.
Figure 7
Model of a spinothalamocortical feedback circuit. Spinal projection neurons relay sensory information to the VPL nucleus of the thalamus. Sensory thalamocortical relay neurons propagate the information directly to CST neurons in S1. S1-CST neurons also receive direct synaptic input from inhibitory (PV) neurons and pyramidal layer 2/3 neurons. S1-CST neurons do not only innervate the spinal cord but also send collaterals to the dorsal striatum (CPu) as well as thalamic nuclei (indicated by dotted green lines with arrow). We speculate that different subpopulations of CST neurons (e.g., RORα+ or RORα−) project back onto different types of spinal interneurons (e.g., inhibitory [GlyT2+, Pax2+] or excitatory [Lmx1β+, CCK+, c-Maf+]) and thus exert potentially modality specific functions (see Discussion). CST neurons likely modulate spinal target neurons through release of glutamate as well as the neuropeptide CCK.